139 related articles for article (PubMed ID: 639696)
41. [Diagnostic value of determining carcino-embryonic antigens in the aqueous humor (author's transl)].
Daxecker F; Zirm M
Klin Monbl Augenheilkd; 1980 Dec; 177(6):768-71. PubMed ID: 7206566
[TBL] [Abstract][Full Text] [Related]
42. [Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma].
Treidler J; Pompecki R; Müllerleile U; Garbrecht M; Kleeberg UR
Onkologie; 1984 Dec; 7(6):328-33. PubMed ID: 6241304
[TBL] [Abstract][Full Text] [Related]
43. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
44. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
Lokich JJ; Zamcheck N; Lowenstein MW
Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
[TBL] [Abstract][Full Text] [Related]
45. Usefulness of serial carcinoembryonic antigen (CEA) determinations in monitoring chemotherapy.
Young VL; Kashmiri R; Hazen ZR; Meeker WR
South Med J; 1976 Oct; 69(10):1274-6. PubMed ID: 982100
[TBL] [Abstract][Full Text] [Related]
46. Carcinoembryonic antigen (CEA) in patients with breast cancer.
Borthwick NM; Wilson DW; Bell PA
Eur J Cancer (1965); 1977 Feb; 13(2):171-6. PubMed ID: 852488
[No Abstract] [Full Text] [Related]
47. [Evaluation of carcinoembryonic antigen level of serum and tumor tissue in breast cancer patients (author's transl)].
Kitamura M; Tominaga T; Kaneko H; Hayashi K; Takahashi I; Saito T; Ito I
Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):35-43. PubMed ID: 6267147
[No Abstract] [Full Text] [Related]
48. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)].
Wurster K; Heberling D; Rapp W
Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937
[No Abstract] [Full Text] [Related]
49. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy.
Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS
Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585
[TBL] [Abstract][Full Text] [Related]
50. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
[TBL] [Abstract][Full Text] [Related]
51. [Serum levels of carcinoembryonic antigen (CEA) and pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast cancer].
Kimoto A; Uemura K; Egami T; Kawaguchi H; Goto H; Miyauchi Y; Yokoyama I
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2022-8. PubMed ID: 7169574
[No Abstract] [Full Text] [Related]
52. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Tormey DC; Waalkes TP; Snyder JJ; Simon RM
Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
[TBL] [Abstract][Full Text] [Related]
53. [Comparative study between carcinoembryonic antigen (CEA) in breast cancer tissue and morphological regional immunoreaction: preliminary report].
Asagoe T; Yamoto H; Hanatani Y; Horie H; Nemoto A; Kidooka K; Shikata J
Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):534. PubMed ID: 2198457
[No Abstract] [Full Text] [Related]
54. [Diagnostic validity of CEA determination in metastasizing breast cancer].
Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
[TBL] [Abstract][Full Text] [Related]
55. Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin.
Waalkes TP; Gehrke CW; Tormey DC; Woo KB; Kuo KC; Synder J; Hansen H
Cancer; 1978 May; 41(5):1871-82. PubMed ID: 647632
[TBL] [Abstract][Full Text] [Related]
56. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
[TBL] [Abstract][Full Text] [Related]
57. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients.
Veronesi A; Talamini R; Longhi S; Crivellari D; Galligioni E; Tirelli U; Trovò MG; Magri MD; Frustaci S; Figoli F; Zagonel V; Tumolo S; Grigoletto E
Tumori; 1982 Dec; 68(6):477-80. PubMed ID: 7168012
[TBL] [Abstract][Full Text] [Related]
58. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
[TBL] [Abstract][Full Text] [Related]
59. [Carcinoembryonic antigen (CEA): its nature and clinical significance].
Franchimont P; Zangerlé PF; Dubucq M; Collette J; Colin C
Rev Med Liege; 1981 Apr; 36(8):366-71. PubMed ID: 7291819
[No Abstract] [Full Text] [Related]
60. Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator.
Shousha S; Lyssiotis T; Godfrey VM; Scheuer PJ
Br Med J; 1979 Mar; 1(6166):777-9. PubMed ID: 435793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
